116 related articles for article (PubMed ID: 29135323)
1. Impact assessment of the rational selection of training and test sets on the predictive ability of QSAR models.
Andrada MF; Vega-Hissi EG; Estrada MR; Garro Martinez JC
SAR QSAR Environ Res; 2017 Dec; 28(12):1011-1023. PubMed ID: 29135323
[TBL] [Abstract][Full Text] [Related]
2. Does rational selection of training and test sets improve the outcome of QSAR modeling?
Martin TM; Harten P; Young DM; Muratov EN; Golbraikh A; Zhu H; Tropsha A
J Chem Inf Model; 2012 Oct; 52(10):2570-8. PubMed ID: 23030316
[TBL] [Abstract][Full Text] [Related]
3. QSAR model for predicting neuraminidase inhibitors of influenza A viruses (H1N1) based on adaptive grasshopper optimization algorithm.
Algamal ZY; Qasim MK; Lee MH; Ali HTM
SAR QSAR Environ Res; 2020 Nov; 31(11):803-814. PubMed ID: 32938208
[TBL] [Abstract][Full Text] [Related]
4. A robust quantitative structure-activity relationship modelling of influenza neuraminidase a/PR/8/34 (H1N1) inhibitors based on the rank-bridge estimator.
Al-Dabbagh ZT; Algamal ZY
SAR QSAR Environ Res; 2019 Jun; 30(6):417-428. PubMed ID: 31122071
[TBL] [Abstract][Full Text] [Related]
5. Rational selection of training and test sets for the development of validated QSAR models.
Golbraikh A; Shen M; Xiao Z; Xiao YD; Lee KH; Tropsha A
J Comput Aided Mol Des; 2003; 17(2-4):241-53. PubMed ID: 13677490
[TBL] [Abstract][Full Text] [Related]
6. PV
Dong Y; Xiang B; Du D
J Chem Inf Model; 2017 May; 57(5):1055-1067. PubMed ID: 28419798
[TBL] [Abstract][Full Text] [Related]
7. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Gao L; Zu M; Wu S; Liu AL; Du GH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
[TBL] [Abstract][Full Text] [Related]
9. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.
Golbraikh A; Tropsha A
J Comput Aided Mol Des; 2002; 16(5-6):357-69. PubMed ID: 12489684
[TBL] [Abstract][Full Text] [Related]
10. Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.
Golbraikh A; Tropsha A
Mol Divers; 2002; 5(4):231-43. PubMed ID: 12549674
[TBL] [Abstract][Full Text] [Related]
11. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
Mercader AG; Pomilio AB
Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898
[TBL] [Abstract][Full Text] [Related]
12. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
13. A QSAR classification model for neuraminidase inhibitors of influenza A viruses (H1N1) based on weighted penalized support vector machine.
Algamal ZY; Qasim MK; Ali HTM
SAR QSAR Environ Res; 2017 May; 28(5):415-426. PubMed ID: 28539063
[TBL] [Abstract][Full Text] [Related]
14. A binary QSAR model for classifying neuraminidase inhibitors of influenza A viruses (H1N1) using the combined minimum redundancy maximum relevancy criterion with the sparse support vector machine.
Qasim MK; Algamal ZY; Ali HTM
SAR QSAR Environ Res; 2018 Jul; 29(7):517-527. PubMed ID: 30037283
[TBL] [Abstract][Full Text] [Related]
15. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
Du QS; Huang RB; Wei YT; Du LQ; Chou KC
J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
Abu Hammad AM; Taha MO
J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
18. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
Li ZS; Sun JY; Liang GZ; Lu FL; Zhu WP; Zhang MJ; Zhang Y; Yang SB; Shu M; Chen GH; Lu TT
Chem Biol Drug Des; 2009 Feb; 73(2):236-43. PubMed ID: 19207426
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and structure-activity relationship of podophyllotoxin and its congeners.
Naik PK; Alam A; Malhotra A; Rizvi O
J Biomol Screen; 2010 Jun; 15(5):528-40. PubMed ID: 20460251
[TBL] [Abstract][Full Text] [Related]
20. Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Y
J Mol Model; 2010 Dec; 16(12):1809-18. PubMed ID: 20213331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
